The tweet was deleted by the author.
But we saved everything 🙂.
Cognizant has been named a Leader in Avasant's Life Sciences Digital Services 2026 RadarView. The stock ranked highest in both practice maturity and future-proofing across 43 evaluated providers.
Avasant assessed 43 providers for its 2026 RadarView. Cognizant held the top position in the rankings.
CTSH is trading well below its key moving averages, with the current price of $43.76 sitting under the SMA-20 at $52.76, the SMA-50 at $53.85, and the SMA-200 at $67.74. This configuration signals a strong bearish structure across short-, medium-, and long-term timeframes, while the Ichimoku Kijun at $51.57 acts as immediate resistance. Near-term support is clustered at the 52-week low ($45.48), with key support at the current price region, while near-term resistance levels are set at the SMA-20 ($52.76) and Kijun ($51.57), with the SMA-50 ($53.85) as a higher barrier.
Momentum indicators on the D1 chart confirm a strong downside bias: MACD and ADX both indicate persistent selling pressure. RSI is at 35.76, leaning into oversold territory, while Stoch RSI and CCI both register oversold signals, pointing to excessive downward momentum. BBP reflects dominance by sellers with a pronounced oversold reading, and the Awesome Oscillator also supports the ongoing downtrend. CTSH has fallen $8.41 (16.00%) over the past week, dropping from a previous close of $52.17. The price now sits at the very bottom of the weekly range, and weekly volatility stands at 7.82%. The weekly movement reflects a steady and forceful decline from the highs. In today’s session, the stock is under heavy selling, down 10.36% so far.
Looking ahead, the anticipated trading range for the next week is adjusted to $42.75–$44.85, based on current price action and the typical volatility for this asset, ensuring prices remain between the recent 52-week low and current levels. Weekly trend indicators (RSI–W1 at 34.28, ADX–W1 at 30.79, MACD–W1 at –7.46, MA-50–W1 all “Sell”) all confirm persistent bearish momentum, implying a very high probability (more than 80%) of further downside and a very low probability of a rebound. The baseline scenario is for CTSH to consolidate within a narrow, oversold range slightly above recent lows. A bullish scenario would require a break above nearby resistance at $45.50–$51.60, but signals make this unlikely. If support at $43.00 fails, a bearish extension toward fresh yearly lows is possible, maintaining the stock’s position at the weaker end of its yearly range ($45.48–$87.03).
Previously it was reported that Cognizant remained under sustained bearish pressure with limited signs of near-term recovery. As market conditions continue to evolve, investors should closely monitor for any shift in technical sentiment that could indicate either ongoing downside risk or an emerging stabilization phase.